Marksans Pharma

Quarterly
Consolidated
ParticularsJun '25Sep '25Dec '25Mar '26Jun '26
Revenue625.63741.98774.57891.28866.20
Expenses549.04608.65623.95691.29659.63
EBITDA105.76166.07180.89230.60238.44
Operating Profit82.67139.15156.56206.31213.57
Profit Before Tax76.60133.34150.62200.00206.57
Net Profit58.2099.14113.69149.03159.41
Financial Ratios
Operating Profit Margin17.06%23.05%23.98%26.94%28.36%
Net Profit Margin9.41%13.64%15.00%17.30%18.69%
Earning Per Share (Diluted)1.292.172.503.273.47
Dividends Per Share0.000.000.000.000.00